Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with

A E Lenferink1, R H Kramer, M J van Vugt

  • 1Department of Cell Biology, University of Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.

Insights

Engineered growth factors, human epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha) chimeras, show superagonist activity. This enhanced potency in stimulating cell growth is linked to receptor recycling following internalization.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Human epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha) are related growth factors binding to the epidermal growth factor receptor (EGFR).
  • While generally similar, TGF-alpha can be more potent than EGF in certain contexts.
  • Ligand-receptor complex processing and internalization differ between EGF and TGF-alpha due to pH-dependent binding.

Purpose of the Study:

  • To compare the mitogenic activity of EGF, TGF-alpha, and their chimeras on cells expressing human EGFR.
  • To investigate the role of receptor binding pH sensitivity and internalization in the activity of these growth factors.

Main Methods:

  • Creation and testing of ten EGF/TGF-alpha chimeras for mitogenic response in EGFR-expressing cells.
  • Measurement of receptor tyrosine kinase activity after ligand binding.
  • Analysis of pH dependence of receptor binding and induction of receptor recycling.

Main Results:

  • Three chimeras (E3T, E4T, T3E4T) exhibited 10-fold higher mitogenic activity than wild-type EGF or TGF-alpha.
  • No differences in receptor tyrosine kinase activity were observed among the tested ligands.
  • Superagonist chimeras showed enhanced pH-dependent binding and induced receptor recycling, similar to TGF-alpha.
  • Superagonist activity was absent in a cell line lacking ligand-induced receptor internalization.

Conclusions:

  • EGF/TGF-alpha chimeras can display enhanced mitogenic potency (superagonism) compared to natural ligands.
  • Receptor recycling following ligand-induced internalization is a critical factor for observing this superagonist phenomenon.
  • The pH sensitivity of ligand-receptor binding influences the efficacy of these growth factors.

Related Concept Videos

Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: